StonvexLoading…
StonvexStonvexStonvexCore line items from MET's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.44B | $2.25B | $2.23B | $2.11B |
Operating Income | $6.14B | $6.00B | $5.72B | $5.98B |
Net Income | $3.38B | $4.43B | $1.58B | $5.28B |
EPS (Diluted) | $4.71 | $5.94 | $1.81 | $6.30 |
Total Assets | $745.17B | $677.46B | $687.58B | $663.07B |
Total Liabilities | $716.25B | $649.75B | $657.33B | $632.95B |
Cash & Equivalents | $22.03B | $20.07B | $20.64B | $20.20B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 655.33M | 689.21M | 730.82M | 779.10M |